Related Experiment Video
Updated: Oct 7, 2025

Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer
Published on: February 13, 2019
Identification of cardiomyopathy-related core genes through human metabolic networks and expression data
Zherou Rong1, Hongwei Chen1, Zihan Zhang1
1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang, China.
Insights
Researchers identified 13 core genes for cardiomyopathy using a multi-omics approach. These genes can help distinguish between dilated cardiomyopathy (DCM) and ischemic cardiomyopathy (ICM), potentially serving as diagnostic biomarkers.
Area of Science:
- Biomedical research
- Genomics
- Systems biology
Background:
- Cardiomyopathy is a complex myocardial disease with increasing incidence.
- Dilated cardiomyopathy (DCM) and ischemic cardiomyopathy (ICM) are common, yet difficult to distinguish, types.
Purpose of the Study:
- To identify core genes capable of differentiating normal, DCM, and ICM samples.
- To discover potential biomarkers for cardiomyopathy diagnosis and subtyping.
Main Methods:
- A systematic multi-omics integration approach was employed.
- Human metabolic network analysis identified candidate gene modules.
- Permutation tests and Markov random field determined a cardiomyopathy risk module.
- Shortest path analysis identified 13 core cardiomyopathy-related genes.
Main Results:
- Thirteen core genes significantly associated with cardiomyopathy were identified.
- These genes are enriched in cardiomyopathy-relevant pathways and functions.
- The identified genes effectively distinguish between normal, DCM, and ICM samples.
Conclusions:
- The 13 core genes may serve as potential biomarkers for cardiomyopathy.
- This research aids in distinguishing between different types of cardiomyopathy.
Background:
Cardiomyopathy is a complex type of myocardial disease, and its incidence has increased significantly in recent years. Dilated cardiomyopathy (DCM) and ischemic cardiomyopathy (ICM) are two common and indistinguishable types of cardiomyopathy.
Results:
Here, a systematic multi-omics integration approach was proposed to identify cardiomyopathy-related core genes that could distinguish normal, DCM and ICM samples using cardiomyopathy expression profile data based on a human metabolic network. First, according to the differentially expressed genes between different states (DCM/ICM and normal, or DCM and ICM) of samples, three sets of initial modules were obtained from the human metabolic network. Two permutation tests were used to evaluate the significance of the Pearson correlation coefficient difference score of the initial modules, and three candidate modules were screened out. Then, a cardiomyopathy risk module that was significantly related to DCM and ICM was determined according to the significance of the module score based on Markov random field. Finally, based on the shortest path between cardiomyopathy known genes, 13 core genes related to cardiomyopathy were identified. These core genes were enriched in pathways and functions significantly related to cardiomyopathy and could distinguish between samples of different states.
Conclusion:
The identified core genes might serve as potential biomarkers of cardiomyopathy. This research will contribute to identifying potential biomarkers of cardiomyopathy and to distinguishing different types of cardiomyopathy.
More Related Videos
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Animal Mitochondrial Genetics

